A genomic signature is derived from the extracted mRNA, specifically analyzing the expression of two genes known to increase in melanoma: PRAME (preferentially expressed antigen in melanoma) and LINC (LINC00518, long intergenic noncoding RNA 518) [231]. This evidence concerns the gene PRAME and melanoma.